RecruitingNCT05618080

LGMD R1 Natural History Study

GRASP-01-003: Trial Readiness and Endpoint Assessment in LGMD R1


Sponsor

Virginia Commonwealth University

Enrollment

100 participants

Start Date

Jan 31, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.


Eligibility

Min Age: 12 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This natural history study follows people with Limb-Girdle Muscular Dystrophy type R1 (LGMD R1), a rare genetic muscle disease caused by mutations in the CAPN3 gene. It causes progressive weakness in the shoulder and hip muscles. The study uses MRI, muscle strength testing, and other assessments over time to track how the disease progresses, which will help researchers design future treatments and clinical trials. You may be eligible if: - You are between 12 and 50 years old - You have confirmed LGMD R1 with genetic testing (homozygous or compound heterozygous mutations in CAPN3) - You have muscle weakness consistent with LGMD R1 - You can walk 10 meters without assistive devices (ankle-foot orthotics are okay) - You are able to provide your own informed consent (adults must consent themselves) You may NOT be eligible if: - You have a contraindication to MRI (e.g., metal implants, severe claustrophobia) - You are unable to walk 10 meters independently - You are pregnant - You have a dominant (not recessive) form of CAPN3 mutation (LGMD D4) - You have another illness that would affect the test results Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(12)

University of California, Irvine

Orange, California, United States

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States

University of Florida

Gainesville, Florida, United States

The Community Health Clinic, Inc.

Shipshewana, Indiana, United States

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

University of Kansas Medical Center

Kansas City, Kansas, United States

University of Minnesota, Department of Neurology

Minneapolis, Minnesota, United States

Washington University School of Medicine

St Louis, Missouri, United States

Nationwide Children's Hospital

Columbus, Ohio, United States

Virginia Commonwealth University

Richmond, Virginia, United States

Leiden University Medical Center

Leiden, Netherlands

Newcastle University

Newcastle upon Tyne, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05618080


Related Trials